-
Featured Authors
-
Archives
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Events
Latest From Events
Syringes for Clinical Trials
Today’s pharmaceutical and biotechnology companies are under pressure to remain competitive. To do so, they require innovative approaches to manage drug development, particularly early development work. Any competitive advantage in the development process is highly prized – and one approach is to begin the development of the compound in a prefilled syringe earlier in the process, rather than later. Traditionally, biopharmaceutical companies have almost exclusively used vials in drug development. There are good reasons for Read More >
Precision Drugs for Bad Bugs
Awareness is high that antibiotic resistance is a critical problem, but many still don’t appreciate the role played by antibiotics themselves in accelerating this problem’s spread. Single antibiotics capable of killing multiple bacterial species – a class of drugs termed “broad spectrum” – have long been seen as a panacea and a cure for all bacterial infections. Today, essentially all marketed antibiotics kill multiple species of bacteria. Unfortunately bacteria that become resistant to a particular Read More >
An Innovation Center for Digital Health
A partnership between Samsung and UCSF opens up opportunities to validate promising sensors and analytics for next-generation digital health solutions Electronics giant Samsung and the University of California, San Francisco (UCSF) are to establish a new digital health innovation lab. To be located in UCSF’s Mission Bay campus in San Francisco, the lab will employ leading researchers and technologists to develop exciting new mobile health technologies; and it will be a test-bed where entrepreneurs and Read More >
Reaction to the $1,000 Genome
System promises to sequence tens of thousands of human whole genomes a year in a single laboratory. What do the first customers think? Life science technology company Illumina recently launched a sequencing platform that it claims will enable the $1,000 genome. The HiSeq X™ Ten Sequencing System comprises 10 ultra-high-throughput sequencers which together can sequence more than 18,000 genomes per year, making human whole-genome sequencing more affordable and accessible than ever before. The system builds Read More >
Hawaii Stands Firm in Biotech Battle
If you drove here in the 1990s, you would see nothing but dead papaya trees,” Hawaii resident Dennis Gonsalves told a newspaper reporter last summer. Gonsalves is a scientist and he is credited with helping to save Hawaii’s Papaya industry. Nearly decimated in the early 1990s by the ringspot virus, the livelihood of Hawaii’s papaya farmers was literally saved by biotechnology and the “Rainbow” papaya, which is genetically-engineered to resist the virus. Rainbow papaya makes Read More >
